UiPath (PATH) Q4 2026 earnings summary

Executive summary

• Achieved full-year GAAP profitability for the first time, with strong Q4 results and revenue and ARR growth year-over-year.

• Q4 ARR reached $1.853 billion, up 11% year-over-year; Q4 revenue was $481 million, up 14% year-over-year.

• Non-GAAP operating income for Q4 was $150 million (31% margin); full-year non-GAAP operating income was $370 million (23% margin).

• Expanded large customer base to 2,565 customers with $100,000+ ARR and 357 customers with $1 million+ ARR.

• Recognized as a leader in autonomous testing platforms by Forrester and launched agentic AI solutions for healthcare.

Financial highlights

• FY26 revenue: $1.611 billion, up 13% year-over-year; Q4 revenue: $481 million, up 14% year-over-year.

• FY26 ARR: $1.853 billion, up 11% year-over-year; dollar-based net retention rate: 107%.

• Q4 GAAP net income: $104 million; full-year GAAP net income: $282 million.

• Q4 adjusted free cash flow: $182 million; full-year: $372 million.

• Ended Q4 with $1.7 billion in cash and no debt.

Outlook and guidance

• FY27 revenue guidance: $1.754–$1.759 billion; ARR: $2.051–$2.056 billion; non-GAAP operating income: ~$415 million.

• Q1 FY27 revenue: $395–$400 million; ARR: $1.894–$1.899 billion.

• FY27 non-GAAP gross margin expected at ~84%; adjusted free cash flow: ~$425 million.

• Stock-based compensation dilution expected at 2–3% for FY27.